Story

Cardinal Health Shares Climb After Extending CVS Distribution Deal to 2032

ENTHMSVIIDZHZH-TWJAKOHI
Oct 1, 20261 min read
Cardinal Health Shares Climb After Extending CVS Distribution Deal to 2032

Summary

The pharmaceutical distributor's stock gained after announcing a long-term extension of its agreement with CVS Health, prompting the company to reaffirm its strong earnings guidance.

Text size
Background

Cardinal Health Inc. (NYSE:CAH) shares rose sharply in Thursday trading after the company announced a significant, long-term extension of its pharmaceutical distribution agreement with CVS Health. The news provides investors with greater certainty over a key revenue stream, bolstering confidence in the company's financial outlook.

Deal Details

Cardinal Health announced it has entered into a binding Letter of Intent to extend its existing distribution agreement with CVS Health. The contract, which maintains its current scope of services, is now set to run through June 30, 2032.

"We value our long-standing partnership with CVS Health and look forward to continuing to bring our best-in-class capabilities together to serve their customers," said Jason Hollar, CEO of Cardinal Health, in a company statement.

Market Reaction and Financial Outlook

Sample IUX Markets – In-articleAd

Following the announcement, shares of Cardinal Health climbed 3.7%. The contract extension provides significant long-term revenue visibility, a key factor for market sentiment.

In connection with the deal, Cardinal Health reaffirmed its key financial targets, including:

  • Fiscal year 2027 non-GAAP EPS growth guidance of 13% to 15%, or $12.40 to $12.60 per share.
  • A long-term non-GAAP EPS growth rate target of 12% to 14%.

The company stated that it may provide further updates during its upcoming first-quarter earnings call, scheduled for November 5, 2026.

Read next

More on Stocks
Back to latest news

LATEST